英文原著

2022

Enomoto A, Fukasawa T, Terunuma H, Nakagawa K, Yoshizaki A, Sato S, Miyagawa K. Decrease in MAP3Ks expression enhances the cell death caused by hyperthermia.Int J Hyperthermia.39(1):200-208,2022

Ozaki S, Kaji S, Nawa K, Imae T, Aoki A, Nakamoto T, Ohta T, Nozawa Y,Yamashita H, Haga A, Nakagawa K. Training of deep cross-modality conversion models with a small dataset, and their application in megavoltage CT to kilovoltage CT conversion. Med Phys. 2022

英文原著

2021

Katano A, Yamashita H, Nakagawa K. Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer. Cureus. 13(2):e13199,2021

Katano A, Takenaka R, Yamashita H, Ando M, Yoshida M, Saito Y, Asakage T, Abe O, Nakagawa K. A retrospective analysis of radiotherapy in the treatment of external auditory canal carcinoma. Mol Clin Oncol.14(3):45,2021

Ogita M, Kawamori J, Yamashita H, Nakagawa K. Palliative radiotherapy for gross hematuria in patients with advanced cancer. Sci Rep.11(1):9533,2021

Indo HP, Ito H, Nakagawa K, Chaiswing L, Majima HJ. Translocation of HSP47 and generation of mitochondrial reactive oxygen species in human neuroblastoma SK-N-SH cells following electron and X-ray irradiation. Arch Biochem Biophys.703:108853,2021

Kitaguchi M, Yamashita H, Takenaka R, Okuma K, Nawa K, Nakagawa K. Helical Skin Radiation Therapy Including Total Skin Radiation Therapy Using Tomotherapy for Primary Cutaneous Lymphoma With Bone Marrow Suppression as a Related Adverse Event. Pract Radiat Oncol.11(3):e308-e321,2021

Katano A, Ishida A, Yamashita H, Nakagawa K. Radiotherapy for symptom palliation of splenomegaly in patients with haematological malignancies. Mol Clin Oncol.14(6):114,2021

Ogita M, Yamashita H, Nozawa Y, Ozaki S, Sawayanagi S, Ohta T,Nakagawa K. Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison. Radiat Oncol.16(1):107,2021

Jinnouchi H, Yamashita H, Kiritoshi T, Miki Y, Katano A, Nakagawa K, Abe O.Prognostic value of pre-treatment maximum standardized uptake value and CRP in radiotherapy of esophageal cancer. Mol Clin Oncol.15(1):146,2021

Katano A, Yamashita H, Nakagawa K. Radical radiotherapy for localized cutaneous angiosarcoma of the scalp. Mol Clin Oncol.15(3):195,2021

Minamitani M, Mukai T, Ogita M, Yamashita H, Katano A, Nakagawa K. Relationship between Consulting for Second Medical Opinions, Radiotherapy, and Satisfaction with Therapy, Analyzed by Structural Equation Modeling: A Web-Based Survey. Asian Pac J Cancer Prev.22(9):2889-2896,2021

Minamitani M, Mukai T, Yamashita H, Katano A, Nakagawa K. Effects on annual income changes after radical radiotherapy versus after prostatectomy in patients with localized prostate cancer with a specific employment status: A web-based pilot study. PLoS One.16(9):e0258116,2021

英文原著

2020

Ito T, Hanafusa N, Iwase S, Noiri E, Nangaku M, Nakagawa K, Miyagawa K. Ascitic IL-10 Concentration Predicts Prognosis of Patients Undergoing Cell-Free and Concentrated Ascites Reinfusion Therapy. Ther Apher Dial.24(1), 90-95, 2020.

Kida S, Kaji S, Nawa K, Imae T, Nakamoto T, Ozaki S, Ohta T, Nozawa Y, Nakagawa K. Visual enhancement of Cone-beam CT by use of CycleGAN. Med Phys.47(3), 998-1010, 2020.

Ogita M, Yamashita H, Sawayanagi S, Takahashi W, Nakagawa K. Efficacy of hydrogel spacer in three-dimensional conformal radiation therapy for prostate cancer. Jpn J Clin Oncol.9;50(3),303-309, 2020.

Aoki S, Yamashita H, Takahashi W, Nawa K, Ota T, Imae T, Ozaki S, Nozawa Y, Nakajima J, Sato M, Anraku M, Nitadori J, Karasaki T, Abe O, Nakagawa K. Salvage stereotactic body radiotherapy for post-operative oligo-recurrence of non-small cell lung cancer: A single-institution analysis of 59 patients. Oncol Lett.19(4), 2695-2704, 2020.

Ogita M, Shiraishi K, Karasawa K, Tokumasu K, Nakajima N, Chang T, Kawamori J, Yamashita H, Nakagawa K: Clinical outcome of adjuvant radiotherapy for squamous cell carcinoma of the breast; a multicenter retrospective cohort study. The Breast 52, 88-94, 2020.

Imae T, Haga A, Watanabe Y, Takenaka S, Shiraki T, Nawa K, Ogita M, Takahashi, W, Yamashita H, Nakagawa K, Abe O. Retrospective dose reconstruction of prostate stereotactic body radiotherapy using cone-beam CT and a log file during VMAT delivery with flattening-filter-free mode. Radiol Phys Technol.13(3):238-248,2020

Imae T, Takenaka S, Watanabe Y, Aoki A, Matsuda K, Sasaki K, Saegusa S, Nawa K, Nakagawa K, Abe O. Surface and build-up dose comparison between Elekta 6 MV flattening filter and flattening-filter-free beams using an advanced Markus ionization chamber and a solid water-equivalent phantom. J Appl Clin Med Phys.21(12):334-339,2020

英文原著

2019

Haga A, Takahashi W, Aoki S, Nawa K, Yamashita H, Abe O, Nakagawa K. Standardization of imaging features for radiomics analysis. J Med Invest. 66(1.2), 35-37, 2019.

Katano A, Yamashita H, Nakagawa K. Successful definitive concurrent chemoradiotherapy in a patient with esophageal cancer and Child-Pugh B cirrhosis of the liver. J Cancer Res Ther. 15(1), 255-257, 2019.

Bhusal Chhatkuli R, Demachi K, Uesaka M, Nakagawa K, Haga A. Development of a markerless tumor-tracking algorithm using prior four-dimensional cone-beam computed tomography. J Radiat Res. 1;60(1), 109-115, 2019.

Satoru Taguchi, Kenshiro Shiraishi, Tetsuya Fujimura, Akihiro Naito, Taketo Kawai, Keiichi Nakagawa, Osamu Abe, Haruki Kume, Hiroshi Fukuhara. Robot-assisted radical prostatectomy versus volumetric modulated arc therapy: Comparison of front-line therapies for localized prostate cancer. Radiotherapy and Oncology 140, 62-67, 2019.

Gonoi W, Okuma H, Hayashi TY, Akahane M, Nakai Y, Tateishi R, Mizuno S, Suzuki, Y, Mitsuda M, Matsuda K, Nakagawa K, Isayama H, Miyagawa K, Koike K, Abe O. Development of pancreatic cancer during observation for hepatocellular carcinoma: A retrospective cohort study. Saudi J Gastroenterol.25(6), 390-396, 2019.

Mizutani T, Magome T, Igaki H, Haga A, Nawa K, Sekiya N, Nakagawa K. Optimization of treatment strategy by using a machine learning model to predict survival time of patients with malignant glioma after radiotherapy.J Radiat Res.22;60(6), 818-824, 2019.

Takenaka R, Haga A, Nawa K, Hideomi Y, Nakagawa K. Improvement of the robustness to set up error by a virtual bolus in total scalp irradiation with Helical TomoTherapy. Radiol Phys Technol.12(4), 433-437, 2019.

Takahashi S, Takahashi W, Tanaka S, Haga A, Nakamoto T, Suzuki Y, Mukasa A, Takayanagi S, Kitagawa Y, Hana T, Nejo T, Nomura M, Nakagawa K, Saito N. Radiomics Analysis for Glioma Malignancy Evaluation Using Diffusion Kurtosis and Tensor Imaging. Int J Radiat Oncol Biol Phys.15;105(4), 784-791, 2019.

Enomoto A, Fukasawa T, Tsumoto H, Karube M, Nakagawa K, Yoshizaki A, Sato S, Miura Y, Miyagawa K. Prevention of calpain-dependent degradation of STK38 by MEKK2-mediated phosphorylation. Sci Rep.5;9(1), 16010, 2019.

Takahashi W, Nawa K, Haga A, Yamashita H, Imae T, Ogita M, Okuma K, Abe O, Nakagawa K. Acceptable fetal dose using flattening filter-free volumetric arc therapy (FFF VMAT) in postoperative chemoradiotherapy of tongue cancer during pregnancy. Clin Transl Radiat Oncol.14;20, 9-12, 2019.

Nakamoto T, Takahashi W, Haga A, Takahashi S, Kiryu S, Nawa K, Ohta T, Ozaki S, Nozawa Y, Tanaka S, Mukasa A, Nakagawa K. Prediction of malignant glioma grades using contrast-enhanced T1-weighted and T2-weighted magnetic resonance images based on a radiomic analysis. Sci Rep.19;9(1), 19411, 2019.

英文原著

2018

Haga A, Takahashi W, Aoki S, Nawa K, Yamashita H, Abe O, Nakagawa K. Classification of early stage non-small cell lung cancers on computed tomographic images into histological types using radiomic features: interobserver delineation variability analysis. Radiol Phys Technol. 11(1), 27-35, 2018.

Aoki S, Yamashita H, Haga A, Nawa K, Imae T, Takahashi W, Abe O, Nakagawa K. Flattening filter-free technique in volumetric modulated arc therapy for lung stereotactic body radiotherapy: A clinical comparison with the flattening filter technique. Oncol Lett. 15(3), 3928-3936, 2018.

Sawayanagi S, Yamashita H, Ogita M, Kiritoshi T, Nakamoto T, Abe O, Nakagawa K. Volumetric and dosimetric comparison of organs at risk between the prone and supine positions in postoperative radiotherapy for prostate cancer. Radiat Oncol. 17;13(1), 70, 2018.

Katano A, Takahashi W, Yamashita H, Yamamoto K, Ando M, Yoshida M, Saito Y, Abe O, Nakagawa K. Radiotherapy alone and with concurrent chemotherapy for nasopharyngeal carcinoma: A retrospective study. Medicine (Baltimore). 97(18), e0502, 2018.

Tsuchiya T, Shiraishi K, Nakagawa K, Kim JR, Kanegasaki S. Identification of the active portion of the CCL3 derivative reported to induce antitumor abscopal effect. Clin Transl Radiat Oncol. 23, 10:7-12, 2018.

Kida S, Nakamoto T, Nakano M, Nawa K, Haga A, Kotoku J, Yamashita H, Nakagawa K. Cone Beam Computed Tomography Image Quality Improvement Using a Deep Convolutional Neural Network. Cureus. 29;10(4), e2548, 2018.

Aoki S, Yamashita H, Haga A, Ota T, Takahashi W, Ozaki S, Nawa K, Imae T, Abe O, Nakagawa K. Stereotactic body radiotherapy for centrally-located lung tumors with 56 Gy in seven fractions: A retrospective study. Oncol Lett. 16(4), 4498-4506, 2018.

英文原著

2017

Takenaka R, Haga A, Yamashita H, Nakagawa K. Adequate target volume in total-body irradiation by intensity-modulated radiation therapy using helical tomotherapy: a simulation study. J Radiat Res. 1;58(2), 210-216, 2017.

Sekiya N, Kuroda Y, Nakajima K, Iwamitsu Y, Kanai Y, Miyashita M, Kotani M, Kitazawa Y, Yamashita H, Nakagawa K. Views on life and death of physicians, nurses, cancer patients and general population in Japan. PLoS One. 3;12(5), e0176648, 2017.

Yamashita H, Seto Y, Takenaka R, Okuma K, Kiritooshi T, Mori K, Yamada K, Fukuda T, Kaminishi M, Abe O, Nakagawa K. Survival comparison between radical surgery and definitive chemoradiation in 267 esophageal squamous cell carcinomas in a single institution: A propensity-matched study. PLoS One. 9;12(5), e0177133, 2017.

Yamashita H, Abe O, Nakagawa K. Involved-field irradiation concurrently combined with nedaplatin/5-fluorouracil for inoperable esophageal cancer on basis of 18FDG-PET scans: A long follow-up results of phase II study. Radiother Oncol. 123(3), 488, 2017.

Keiichi Nakagawa, Kanabu Nawa, Masatoshi Hashimoto, Shuri Aoki, Yoshihiro Kaneko,Hideomi Yamashita, Akihiro Haga A Half-Arc Multiple Deep-Inspiration Breath-Hold Volumetric Modulated Arc Therapy for a Lung Tumor with 10 MV Flattening-Filter-Free Beams and an Image Sensor Measuring a Distance Map to Thorax Surface: An Initial Clinical Experience.　International Journal of Medical Physics, Clinical Engineering and Radiation Oncology.6, 31-35, 2017.

Sakata D, Haga A, Kida S, Imae T, Takenaka S, Nakagawa K. Effective atomic number estimation using kV-MV dual-energy source in LINAC. Phys Med. 39, 9-15, 2017.

Sakuramachi M, Igaki H, Ikemura M, Yamashita H, Okuma K, Sekiya N, Hayakawa Y, Sakumi A, Takahashi W, Hasegawa H, Fukayama M, Nakagawa K. Detection of residual metastatic tumor in the brain following Gamma Knife radiosurgery using a single or a series of magnetic resonance imaging scans: An autopsy study. Oncol Lett. 14(2), 2033-2040, 2017.

Nakano M, Haga A, Kotoku J, Magome T, Masutani Y, Hanaoka S, Kida S, Nakagawa K. Cone-beam CT reconstruction for non-periodic organ motion using time-ordered chain graph model. Radiat Oncol. 4;12(1), 145, 2017.

Yamashita H, Ishihara S, Nozawa H, Kawai K, Kiyomatsu T, Okuma K, Abe O, Watanabe T, Nakagawa K. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions witt conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis. Radiat Oncol. 21;12(1), 156, 2017.

Karube M, Yamamoto N, Tsuji H, Kanematsu N, Nakajima M, Yamashita H, Nakagawa K, Kamada T. Carbon-ion re-irradiation for recurrences after initial treatment of stage I non-small cell lung cancer with carbon-ion radiotherapy. Radiother Oncol. 125(1), 31-35, 2017.

Katano A, Yamashita H, Nakagawa K. Re-irradiation of locoregional esophageal cancer recurrence following definitive chemoradiotherapy: A report of 6 cases. Mol Clin Oncol. 7(4), 681-686, 2017.

Nawa K, Haga A, Nomoto A, Sarmiento RA, Shiraishi K, Yamashita H, Nakagawa K. Evaluation of a commercial automatic treatment planning system for prostate cancers. Med Dosim. 42(3), 203-209, 2017.

Katano A, Yamashita H, Nakagawa K. Stereotactic body radiotherapy for oligo-recurrence in the liver in a patient with esophageal carcinoma: A case report. Mol Clin Oncol. 7(6), 1061-1063, 2017.

Katano A, Takahashi W, Yamashita H, Yamamoto K, Ando M, Yoshida M, Saito Y, Abe O, Nakagawa K. The impact of elevated C-reactive protein level on the prognosis for oro-hypopharynx cancer patients treated with radiotherapy. Sci Rep. 19;7(1), 17805, 2017.

Yamashita H, Ishihara S, Nozawa H, Kawai K, Kiyomatsu T, Okuma K, Abe O, Watanabe T, Nakagawa K. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis. Radiat Oncol. 21;12(1), 156, 2017.

英文原著

2016

Okuma K, Yamashita H, Yokoyama T, Nakagawa K, Kawana K. Undetected human papillomavirus DNA and uterine cervical carcinoma: Association with cancer recurrence. Strahlenther Oncol.192(1), 55-62, 2016.

Yamashita H, Haga A, Takenaka R, Kiritoshi T, Okuma K, Ohtomo K, Nakagawa K. Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer. Radiat Oncol. 19, 11:4, 2016.

Sakumi A, Miyagawa R, Tamari Y, Nawa K, Sakura O, Nakagawa K. External effective radiation dose to workers in the restricted area of the Fukushima Daiichi Nuclear Power Plant during the third year after the Great East Japan Earthquake. J Radiat Res. 57(2), 178-81, 2016.

Kobayashi R, Yamashita H, Okuma K, Ohtomo K, Nakagawa K. Details of recurrence sites after definitive radiation therapy for cervical cancer. J Gynecol Oncol. 27(2), e16, 2016.

Shibata S, Shiraishi K, Yamashita H, Kobayashi R, Nakagawa K. Radiation-induced low-grade fibromyxoid sarcoma of the chest wall nine years subsequent to radiotherapy for breast carcinoma: A case report. Oncol Lett.11(4), 2520-2524, 2016.

Karube M, Yamamoto N, Nakajima M, Yamashita H, Nakagawa K, Miyamoto T, Tsuji H, Fujisawa T, Kamada T. Single-Fraction Carbon-Ion Radiation Therapy for Patients 80 Years of Age and Older with Stage I Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 1;95(1), 542-8, 2016.

Katano A, Yamashita H, Okuma K, Nakagawa K. Complete response to abdominal bulky lymph node recurrence in an esophageal cancer patient treated with S-1 monotherapy: A case report. Oncol Lett.11(6), 3901-3903, 2016.

Yamashita H, Niibe Y, Yamamoto T, Katsui K, Jingu K, Kanazawa S, Terahara A, Nakagawa K. Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases. Jpn J Clin Oncol. 46(7), 687-91, 2016.

Tamari Y, Kuroda Y, Miyagawa R, Nawa K, Sakumi A, Sakata N, Mizushima N, Sakura O, Iwamitsu Y, Takemura K, Nakagawa K. A report that Fukushima residents are concerned about radiation from Land, Food and Radon. J Radiat Res. 57(4), 418-21, 2016.

Yamashita H, Takenaka R, Okuma K, Ootomo K, Nakagawa K. Prognostic factors in patients after definitive chemoradiation using involved-field radiotherapy for esophageal cancer in a phase II study. Thorac Cancer. 7(5), 564-569, 2016.

Taguchi S, Shiraishi K, Fukuhara H, Nakagawa K, Morikawa T, Naito A, Kakutani S, Takeshima Y, Miyazaki H, Nakagawa T, Fujimura T, Kume H, Homma Y. Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial? Radiat Oncol. 30, 11:102, 2016.

Karube M, Mori S, Tsuji H, Yamamoto N, Nakajima M, Nakagawa K, Kamada T. Carbon-ion pencil beam scanning for thoracic treatment – initiation report and dose metrics evaluation. J Radiat Res.57(5), 576-581, 2016.

Taguchi S, Shiraishi K, Fukuhara H, Nakagawa K, Morikawa T, Naito A, Kakutani S, Takeshima Y, Miyazaki H, Nakagawa T, Fujimura T, Kume H, Homma Y. Impact of Gleason pattern 5 including tertiary pattern 5 on outcomes of salvage treatment for biochemical recurrence in pT2-3N0M0 prostate cancer. Int J Clin Oncol.21(5), 975-980, 2016.

Okuma K, Shiraishi K, Kanai Y, Nakagawa K. Improvement in quality of life by using duloxetine for chemotherapy-induced peripheral neuropathy (CIPN): a case report. Support Care Cancer. 24(11), 4483-5, 2016.

Kobayashi R, Miyagawa R, Yamashita H, Morikawa T, Okuma K, Fukayama M, Ohtomo K, Nakagawa K. Increased expression of long non-coding RNA XIST predicts favorable prognosis of cervical squamous cell carcinoma subsequent to definitive chemoradiation therapy. Oncol Lett.12(5), 3066-3074, 2016.

Takenaka R, Yamashita H, Toya T, Haga A, Shibata S, Kurokawa M, Ootomo K, Nakagawa K. Unique radiation dermatitis related to total body irradiation by helical tomotherapy. J Dermatol. 43(11), 1376-1377, 2016.

Magome T, Froelich J, Takahashi Y, Arentsen L, Holtan S, Verneris MR, Brown K, Haga A, Nakagawa K, Holter Chakrabarty JL, Giebel S, Wong J, Dusenbery K, Storme G, Hui SK. Evaluation of Functional Marrow Irradiation Based on Skeletal Marrow Composition Obtained Using Dual-Energy Computed Tomography. Int J Radiat Oncol Biol Phys. 1;96(3), 679-87, 2016.

Magome T, Haga A, Takahashi Y, Nakagawa K, Dusenbery KE, Hui SK. Fast Megavoltage Computed Tomography: A Rapid Imaging Method for Total Body or Marrow Irradiation in Helical Tomotherapy. Int J Radiat Oncol Biol Phys. 1;96(3), 688-95, 2016.

英文原著

2015

Kobayashi R, Shiraishi K, Iwase S, Ohtomo K, Nakagawa K. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients. Breast Cancer. 22(6), 657-63, 2015.

Kuroda Y, Iwamitsu Y, Miyashita M, Hirai K, Kanai Y, Kawakami S, Nakano K, Nakagawa K. Views on death with regard to end-of-life care preferences among cancer patients at a Japanese university hospital. Palliat Support Care. 13(4), 969-79, 2015.

Ito T, Hanafusa N, Iwase S, Noiri E, Nangaku M, Nakagawa K, Miyagawa K. Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites. Int J Clin Oncol.20(3), 623-8, 2015.

Miyashita M, Kawakami S, Kato D, Yamashita H, Igaki H, Nakano K, Kuroda Y, Nakagawa K. The importance of good death components among cancer patients, the general population, oncologists, and oncology nurses in Japan: patients prefer “fighting against cancer”. Support Care Cancer.23(1), 103-10, 2015.
Yamashita H, Takenaka R, Sakumi A, Haga A, Otomo K, Nakagawa K. Analysis of motion of the rectum during preoperative intensity modulated radiation therapy for rectal cancer using cone-beam computed tomography. Radiat Oncol.8, 10, 2, 2015.

Takahashi W, Nakajima M, Yamamoto N, Yamashita H, Nakagawa K, Miyamoto T, Tsuji H, Kamada T, Fujisawa T. A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC). Cancer. 2015.

Yamashita H, Onishi H, Murakami N, Matsumoto Y, Matsuo Y, Nomiya T, Nakagawa K; Japanese Radiological Society multi-institutional SBRT study group (JRS-SBRTSG). Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma. J Radiat Res.56(3), 561-7, 2015.

Yamashita M, Yamashita H, Shibata S, Okuma K, Nakagawa K. Symptom relief effect of palliative high dose rate intracavitary radiotherapy for advanced esophageal cancer with dysphagia. Oncol Lett. 9(4), 1747-1752, 2015.

Okuma K, Yamashita H, Kobayashi R, Nakagawa K. A study of high-dose-rate intracavitary brachytherapy boost for curative treatment of uterine cervical cancer. J Contemp Brachytherapy. 7(2), 128-34, 2015.

Katano A, Takenaka R, Okuma K, Yamashita H, Nakagawa K. Repeated episodes of spontaneous regression/progression of cervical adenocarcinoma after adjuvant chemoradiation therapy: a case report. J Med Case Rep. 19, 9:114, 2015.

Aoyama H, Tago M, Shirato H; Japanese Radiation Oncology Study Group 99-1 (JROSG 99-1) Investigators. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial. JAMA Oncol. 1(4), 457-64, 2015.

Yamashita H, Takenaka R, Omori M, Imae T, Okuma K, Ohtomo K, Nakagawa K. Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study. Radiat Oncol. 14, 10:171, 2015.
Niibe Y, Yamashita H, Sekiguchi K, Takahashi W, Shiraishi K, Okuma K, Terahara A, Kawamori J, Nakagawa K. Stereotactic Body Radiotherapy Results for Pulmonary Oligometastases: A Two-Institution Collaborative Investigation. Anticancer Res.35(9), 4903-8, 2015.

Taguchi S, Fukuhara H, Shiraishi K, Nakagawa K, Morikawa T, Kakutani S, Takeshima Y, Miyazaki H, Fujimura T, Nakagawa T, Kume H, Homma Y. Radical Prostatectomy versus External Beam Radiotherapy for cT1-4N0M0 Prostate Cancer: Comparison of Patient Outcomes Including Mortality. PLoS One. 27;10(10), e0141123, 2015.

Kobayashi R, Shiraishi K, Iwase S, Ohtomo K, Nakagawa K. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients. Breast Cancer. 22(6), 657-63, 2015.

Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Kozuka T, Kunieda E, Saito T, Nakagawa K, Hareyama M, Takai Y, Hayakawa K, Mitsuhashi N, Ishikura S. Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys. 1;93(5), 989-96, 2015.

英文原著

2014

Yamashita, H., Omori, M., Okuma, K., Kobayashi, R., Igaki, H., and Nakagawa, K. Longitudinal assessments of quality of life and late toxicities before and after definitive chemoradiation for esophageal cancer. Jpn J Clin Oncol. 44(1), 78-84, 2014.

Yamashita, H., Onishi, H., Matsumoto, Y., Murakami, N., Matsuo, Y., Nomiya, T., Nakagawa, K. and Japanese Radiological Society multi-institutional SBRT study group (JRS-SBRTSG). Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients. Radiat Oncol. 9(1), 112, 2014. doi: 10.1186/1748-717X-9-112.

Kobayashi, R., Shiraishi, K., Iwase, S., Ohtomo, K. and Nakagawa, K. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients. Breast Cancer. 2014 Apr 23. [Epub ahead of print] PubMed PMID:24756246.

Yamashita, H., Yamashita, M., Futaguchi, M., Takenaka, R., Shibata, S., Yamamoto, K., Nomoto, A., Sakumi, A., Kida, S., Kaneko, Y., Takenaka, S., Shiraki, T. and Nakagawa, K. Individually wide range of renal motion evaluated by four-dimensional computed tomography. Springerplus. 3, 131, 2014. doi: 10.1186/2193-1801-3-131.

Haga, A., Magome, T., Takenaka, S., Imae, T., Sakumi, A., Nomoto, A., Igaki, H., Shiraishi, K., Yamashita, H., Ohtomo, K. and Nakagawa, K. Independent absorbed-dose calculation using the Monte Carlo algorithm in volumetric modulated arc therapy. Radiat Oncol. 9, 75, 2014. doi: 10.1186/1748-717X-9-75.

Takahashi, W., Nakajima, M., Yamamoto, N., Yamada, S., Yamashita, H., Nakagawa, K., Tsuji, H. and Kamada, T. Carbon ion radiotherapy for oligo-recurrent lung metastases from colorectal cancer: a feasibility study. Radiat Oncol. 9, 68, 2014. doi:10.1186/1748-717X-9-68.

Yamashita, H., Okuma, K., Nomoto, A., Yamashita, M., Igaki, H. and Nakagawa, K. Extended cancer-free survival after palliative chemoradiation for metastatic esophageal cancer. World J Gastrointest Oncol. 6(2), 52-54, 2014.

Yamashita, H., Omori, M., Okuma, K., Kobayashi, R., Igaki, H. and Nakagawa, K. Longitudinal assessments of quality of life and late toxicities before and after definitive chemoradiation for esophageal cancer. Jpn J Clin Oncol. 44(1), 78-84, 2014.

Nakagawa, K., Haga, A., Sakumi, A., Yamashita, H., Igaki, H., Shiraki, T., Ohtomo, K., Iwai, Y. and Yoda, K. Impact of flattening-filter-free techniques on delivery time for lung stereotactic volumetric modulated arc therapy and image quality of concurrent kilovoltage cone-beam computed tomography: a preliminary phantom study. J Radiat Res. 55(1), 200-202, 2014.

Imae, T., Haga, A., Saotome, N., Kida, S., Nakano, M., Takenaka, S., Takeuchi, Y., Shiraki, T., Yano, K., Yamashita, H., Nakagawa, K. and Ohtomo, K. Dose Reconstruction Using Respiratory Signals and Machine Parameters during Treatment in Stereotactic Body Radiotherapy. Nihon Hoshasen Gijutsu Gakkai Zasshi. 70(11), 1225-1234, 2014.

Yamashita, H., Haga, A., Takahashi, W., Takenaka, R., Imae, T., Takenaka, S. and Nakagawa, K. Volumetric modulated arc therapy for lung stereotactic radiation therapy can achieve high local control rates. Radiat Oncol. 9(1), 243, 2014.

Takahashi, W., Mori, S., Nakajima, M., Yamamoto, N., Inaniwa, T., Furukawa, T., Shirai, T., Noda, K., Nakagawa, K. and Kamada, T. Carbon-ion scanning lung treatment planning with respiratory-gated phase-controlled rescanning: simulation study using 4-dimensional CT data. Radiat Oncol. 9(1), 238, 2014.

Yamashita, H., Takahashi, W., Haga, A. and Nakagawa, K. Radiation pneumonitis after stereotactic radiation therapy for lung cancer. World J Radiol. 6(9), 708-715, 2014.

Ito, T., Hanafusa, N., Iwase, S., Noiri, E., Nangaku, M., Nakagawa, K. and Miyagawa, K. Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites. Int J Clin Oncol. 2014 Sep 20. [Epub ahead of print] PMID: 25239690

Igaki, H., Sakumi, A., Mukasa, A., Saito, K., Kunimatsu, A., Masutani, Y., Hanakita, S., Ino, K., Haga, A., Nakagawa, K. and Ohtomo, K. Corticospinal tract-sparing intensity-modulated radiotherapy treatment planning. Rep Pract Oncol Radiother. 19(5), 310-316, 2014.

Yamashita, H., Takahashi, W., Haga, A., Kida, S., Saotome, N. and Nakagawa, K. Stereotactic body radiotherapy for small lung tumors in the University of Tokyo Hospital. Biomed Res Int. 2014;2014:136513. doi: 10.1155/2014/136513. Epub 2014 Jul 7. PMID: 25110653

Kanegasaki, S., Matsushima, K., Shiraishi, K., Nakagawa, K. and Tsuchiya, T. Macrophage inflammatory protein derivative ECI301 enhances the alarmin-associated abscopal benefits of tumor radiotherapy. Cancer Res. 74(18), 5070-5078, 2014. doi: 10.1158/0008-5472.CAN-14-0551.

Kuroda, Y., Iwamitsu, Y., Miyashita, M., Hirai, K., Kanai, Y., Kawakami, S., Nakano, K. and Nakagawa, K. Views on death with regard to end-of-life care preferences among cancer patients at a Japanese university hospital. Palliat Support Care. 2014 Jul 11:1-11. [Epub ahead of print] PMID: 25014469 [PubMed – as supplied by publisher]

Miyashita, M., Kawakami, S., Kato, D., Yamashita, H., Igaki, H., Nakano, K., Kuroda, Y. and Nakagawa, K. The importance of good death components among cancer patients, the general population, oncologists, and oncology nurses in Japan: patients prefer “fighting against cancer” Support Care Cancer. 2014 Jul 5. [Epub ahead of print] PMID: 24996829 [PubMed – as supplied by publisher]

Shiraishi, K., Futaguchi, M., Haga, A., Sakumi, A., Sasaki, K., Yamamoto, K., Igaki, H., Ohtomo, K., Yoda, K. and Nakagawa, K. Validation of planning target volume margins by analyzing intrafractional localization errors for 14 prostate cancer patients based on three-dimensional cross-correlation between the prostate images of planning CT and intrafraction cone-beam CT during volumetric modulated arc therapy. Biomed Res Int. 2014;2014:960928. doi: 10.1155/2014/960928. Epub 2014 May 22. PMID: 24977167 [PubMed – in process]

Nakagawa, K., Haga, A., Sasaki, K., Kida, S., Masutani, Y., Yamashita, H., Takahashi, W., Igaki, H., Sakumi, A., Ohtomo, K. and Yoda, K. Lung tumor motion reproducibility for five patients who received four-fraction VMAT stereotactic ablative body radiotherapy under constrained breathing conditions: a preliminary study. J Radiat Res. 55(6), 1199-1201, 2014.

Yamashita H, Omori M, Takenaka R, Okuma K, Kobayashi R, Ohtomo K, Nakagawa K. Involved-field irradiation concurrently combined with nedaplatin/5-fluorouracil for inoperable esophageal cancer on basis of (18)FDG-PET scans: a phase II study. Radiother Oncol. 2014 Nov;113(2):182-7. doi: 10.1016/j.radonc.2014.11.004. Epub 2014 Nov 23. PubMed PMID: 25466372.

Yamashita M, Takenaka HY, Nakagawa K. Semi-radical chemoradiotherapy for 53 esophageal squamous cell carcinomas with supraclavicular lymph node metastasis in a single institutional retrospective study. Hepatogastroenterology. 2014 Oct;61(135):1971-8. PubMed PMID: 25713897.

Yamashita H, Takenaka R, Sakumi A, Haga A, Otomo K, Nakagawa K. Analysis of motion of the rectum during preoperative intensity modulated radiation therapy for rectal cancer using cone-beam computed tomography. Radiat Oncol. 2015 Jan 8;10(1):2. [Epub ahead of print] PubMed PMID: 25566869; PubMed Central PMCID: PMC4312441.

Takahashi W, Nakajima M, Yamamoto N, Yamashita H, Nakagawa K, Miyamoto T, Tsuji H, Kamada T, Fujisawa T. A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC). Cancer. 2015 Jan 13. doi: 10.1002/cncr.29195. [Epub ahead of print] PubMed PMID: 25641119.

Yamashita H, Onishi H, Murakami N, Matsumoto Y, Matsuo Y, Nomiya T, Nakagawa K; Japanese Radiological Society multi-institutional SBRT study group (JRS-SBRTSG). Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma. J Radiat Res. 2015 Feb 16. pii: rru130. [Epub ahead of print] PubMed PMID: 25691453.

Yamashita M, Yamashita H, Shibata S, Okuma K, Nakagawa K. Symptom relief effect of palliative high dose rate intracavitary radiotherapy for advanced esophageal cancer with dysphagia. Oncol Lett. 2015 Apr;9

NAGATA, Yasushi, et al. Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys, 2015; 93.5: 989-996.

英文原著

2013

Hama, Y. and Nakagawa, K. Early distant relapse in early stage triple-negative breast cancer: usefulness of FDG-PET for diagnosis of distant metastases. Breast Cancer. 20(2), 2013.

Fukui, M., Iwase, S., Sakata, N., Kuroda, Y., Yoshiuchi, K., Nakagawa, K., Quinn, K. and Hudson, P. L. Effectiveness of using clinical guidelines for conducting palliative care family meetings in Japan. Support Care Cancer. 21(1), 53-58, 2013.

Matsuo, Y., Onishi, H., Nakagawa, K., Nakamura, M., Ariji, T., Kumazaki, Y., Shimbo, M., Tohyama, N., Nishio, T., Okumura, M., Shirato, H. and Hiraoka, M. Guidelines for respiratory motion management in radiation therapy. J Radiat Res. 54(3), 561-568, 2013.

Shibata-Kobayashi, S., Yamashita, H., Okuma, K., Shiraishi, K., Igaki, H., Ohtomo, K. and Nakagawa, K. Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-α, NF-κB, TGF-β, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1α] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma. Oncol Lett. 5(3), 903-910, 2013.

Onoe, T., Nose, T., Yamashita, H., Yoshioka, M., Toshiyasu, T., Kozuka, T., Oguchi, M. and Nakagawa, K. High-dose-rate interstitial brachytherapy for gynecologic malignancies–dosimetric changes during treatment period. J Radiat Res. 54(4), 663-670, 2013.

Haga, A., Sakumi, A., Okano, Y., Itoh, S., Saotome, N., Kida, S., Igaki, H., Shiraishi, K., Yamashita, H., Ohtomo, K. and Nakagawa, K. Dose verification of volumetric modulated arc therapy (VMAT) by use of in-treatment linac parameters. Radiol Phys Technol. 6(2), 335-342, 2013.

Takahashi, W., Yamashita, H., Omori, M., Kitaguchi, M., Shibata-Kobayashi, S., Sakumi, A. and Nakagawa, K. The feasibility and efficacy of stereotactic body radiotherapy for centrally-located lung tumors. Anticancer Res. 33(11), 4959-4964, 2013.

Igaki, H., Onishi, H., Nakagawa, K., Dokiya, T., Nemoto, K., Shigematsu, N., Nishimura, Y. and Hiraoka, M. A newly introduced comprehensive consultation fee in the national health insurance system in Japan: a promotive effect of multidisciplinary medical care in the field of radiation oncology–results from a questionnaire survey. Jpn J Clin Oncol. 43(12), 1233-1237, 2013.

Omori, M., Yamashita, H., Shinohara, A., Kurokawa, M., Takita, J., Hiwatari, M. and Nakagawa, K. Eleven secondary cancers after hematopoietic stem cell transplantation using a total body irradiation-based regimen in 370 consecutive pediatric and adult patients. Springerplus. 2, 424, 2013.

Matsuo, Y., Onishi, H., Nakagawa, K., Nakamura, M., Ariji, T., Kumazaki, Y., Shimbo, M., Tohyama, N., Nishio, T., Okumura, M., Shirato, H. and Hiraoka, M. Guidelines for respiratory motion management in radiation therapy. J Radiat Res. 54(3), 561-568, 2013.